AbbVie stock after-hours at EUR 232.05: plus 0.15 percent versus the Lang & Schwarz prior close
Published on 10/02/2026 at 19:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
AbbVie stock was at EUR 232.05 after-hours at 7:21 p.m. CEST on October 2, 2026, up plus 0.15 percent versus the prior close of EUR 231.70 at Lang & Schwarz.
Trading day
The Lang & Schwarz quote showed a bid of EUR 231.80 and an ask of EUR 232.30. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of AbbVie stock.
RINVOQ vitiligo data
In a PR Newswire release dated October 1, 2026, AbbVie reported late-breaking results from the ongoing Phase 3 Viti-Up-1 and Viti-Up-2 studies of RINVOQ in non-segmental vitiligo. Among patients continuing RINVOQ 15 mg once daily, the proportion achieving at least 75 percent facial repigmentation rose from 33.1 percent at week 48 to 55.1 percent at week 76 in Viti-Up-1, and from 27.6 percent to 47.4 percent in Viti-Up-2.
Quarterly dividend
AbbVie’s board declared a quarterly cash dividend of USD 1.73 per share on September 10, 2026, according to a PR Newswire release. The dividend is payable November 16, 2026, to stockholders of record at the close of business on October 15, 2026.
